RI S2563

Directs the Rhode Island Office of the Auditor General to conduct an independent study evaluating whether consolidating Medicaid prescription drug management would benefit the state, with a report due by March 31, 2027

Requires the study to compare four management structures: the current system using multiple managed care organizations and pharmacy benefit managers, a single statewide preferred drug list, a single state-contracted pharmacy benefit manager, and a state-administered fee-for-service model

Mandates that pharmacy benefit managers, managed care organizations, and all related entities provide complete, unredacted access to records on claims, rebates, contracts, fees, and pricing data upon request by the Auditor General

Authorizes the Auditor General to contract with independent pharmacy pricing and audit consultants to conduct the evaluation of cost savings, administrative efficiency, and beneficiary access impacts

Grants enforcement authority to the Office of the Auditor General and the Attorney General, with protections for confidential commercial information while prohibiting entities from using confidentiality claims to withhold data from auditors